Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Terminated
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8
- Interventions
- Behavioral: Behavioral AssessmentOther: Electronic Health Record Review
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT04835597
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
Not Applicable
Active, not recruiting
- Conditions
- Advanced Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
- Interventions
- Other: Educational InterventionOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationOther: Resistance Training
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT04837118
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer
Phase 2
Withdrawn
- Conditions
- Recurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
- Interventions
- Other: Hafnium Oxide-containing Nanoparticles NBTXR3Procedure: Intensity-Modulated Proton TherapyBiological: PembrolizumabOther: Quality-of-Life AssessmentRadiation: Intensity-Modulated Radiation TherapyOther: Questionnaire AdministrationRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT04834349
Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training
Recruiting
- Conditions
- Malignant Vascular Neoplasm
- Interventions
- Other: Survey Administration
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT04832698
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Development of a Patient Decision Aid for Women Considering Breast Reconstruction
Completed
- Conditions
- Breast Carcinoma
- Interventions
- Other: Educational InterventionOther: Usual CareOther: Media InterventionOther: Questionnaire AdministrationOther: Medical Chart Review
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2021-05-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 126
- Registration Number
- NCT04817709
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor
Phase 3
Recruiting
- Conditions
- Locally Advanced Neuroendocrine NeoplasmMetastatic Neuroendocrine Neoplasm
- Interventions
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT04810091
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers
Not Applicable
Recruiting
- Conditions
- Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
- Interventions
- Behavioral: Behavioral InterventionOther: InterviewOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 104
- Registration Number
- NCT04810052
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths
Early Phase 1
Completed
- Conditions
- Healthy Subject
- Interventions
- Behavioral: Preventive InterventionBehavioral: Questionnaire Administration
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2021-03-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 94
- Registration Number
- NCT04803682
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor
Phase 1
Terminated
- Conditions
- Unresectable Malignant Solid NeoplasmLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
- Interventions
- Biological: PembrolizumabDrug: Pevonedistat
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT04800627
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
Not Applicable
Active, not recruiting
- Conditions
- Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Resectable Colorectal CarcinomaStage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8Metastatic Malignant Neoplasm in the Liver
- Interventions
- Procedure: Diffusion Weighted Imaging
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04796818
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath